logo
[breadcrumb_custom]

Tag: (CYTO)

Industry

Altamira Therapeutics Ltd (CYTO) Stock: Navigating Drops and Gains

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Altamira Therapeutics Ltd’s current trading price is -95.08% away from its 52-week high, while its distance from the 52-week low is 59.01%. The stock’s price range for this time frame has been between $1.61 and $52.00. The trading volume of the company’s shares in the Healthcare reached around 51.78 million for the day, which was evidently higher than the average daily volume of 0.19 million over the last three months. The market performance of Altamira Therapeutics Ltd has been

Industry

CYTO’s Market Whiplash: -30.17% YTD Decline, 31.35% Rise in 30 Days

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Year to date metric has recorded a loss of -30.17%.However, over the last six months, we can see a stronger performance of -64.39%. Over the last 30 days, the price of CYTO has fallen by 31.35%. And in the last five days, it has surged by 35.00%. Altamira Therapeutics Ltd had a pretty Dodgy run when it comes to the market performance. Over